Facebook
Twitter
LinkedIn
Forward5th Annual Midwest Endoscopy Group Meeting: Evidence for Everyday Clinical Challenges
Program Format
This activity will be held in-person at the Hyatt Regency Milwaukee, 333 West Kilbourn Avenue, Milwaukee, Wisconsin.
Program Overview
This activity focuses on advances in GI Endoscopy.
Target Audience
This activity is designed to meet the needs of gastroenterologists, oncologists, radiologists, surgeons, advanced prescribing practitioners, and GI nurses.
Objectives
As a result of participation in this educational activity, members of the healthcare team will be able to:
- Describe the evidence of management of the everyday clinical issues
- Outline newer treatment options for gastrointestinal neoplasia
- Identify principles of surveillance and treatment of early GI cancers
Elements of Competence
This activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of patient care and procedural skills, practice based learning and improvement, and medical knowledge, in addition to the interprofessional competencies of roles/responsibilities and teams/teamwork.
Registration Fees
- Physicians, Advanced Practice Providers: $50
- Nurses, Technicians, Students: $25
Cancellation and Refund Policy
Requests for cancellation must be submitted in writing to help@icep.wisc.edu. Cancellation requests received at least 96 hours prior to the conference will allow a full refund except for the nonrefundable processing fee of $25. No refunds will be made for cancellations received less than 96 hours prior to the activity start date.
Saturday, November 5, 2022
| 7:00 AM | Registration, Breakfast |
| 8:00 AM | Inauguration of the Meeting, Dr. Nalini Guda; Dr. Patrick Pfau; Dr. Kulwinder Dua |
| 8:10 AM | Endoscopic Therapy of Barrett's Esophagus Related Dysplasia and Neoplasia - Recent Advances, Dr. Prasad Iyer, Mayo Clinic, Rochester, Minnesota |
| 8:30 AM | Supraesophageal Manifestations of GERD - How to Investigate and Manage, Dr. Reza Shaker, Medical College of Wisconsin, Milwaukee, Wisconsin |
| 8:50 AM | Post H. Pylori Treatment: Should You Routinely Retest and Retreat - What Are the Ideal Treatments? Dr. Nimish Vakil, Milwaukee Wisconsin |
| 9:10 AM | Discussions |
| 9:30 AM | Obscure GI Bleed - What To Do When Deep Enteroscopy Does Not Resolve the Issue? Repeat Interventions or Time for Medical Therapy? Dr. Carol Semrad, University of Chicago, Chicago, Illinois |
| 9:50 AM | EUS Gastrojejunostomy - Time to Put the Scalpel Away, Dr. Uzma Siddiqui, University of Chicago, Chicago, Illinois |
| 10:10 AM | Discussions/Break |
| 10:30 AM | Choosing the Right Stent for the Bile Duct - When Is Plastic a Better Option, Dr. Martin Freeman, University of Minnesota Medical School, Minneapolis, Minnesota |
| 10:50 AM | ERCP, Altered Anatomy - Do We Still Need Surgery for ERCP? Dr. Rajeev Attam, Kaiser Permanente Downey Medical Center, Downey, California |
| 11:10 AM | Pancreatic Necrosis - To Intervene or Not to Intervene, Dr. John DeWitt, Indiana University Health, Indianapolis, Indiana |
| 11:30 AM | Pancreatic Cyst Surveillance - When Do You Test the Fluid and When Do We Stop Surveillance, Dr. Amitabh Chak, Case Western Reserve University, Cleveland, Ohio |
| 11:50 AM | Discussions |
| 12:00 PM | Lunch, View Exhibits |
| 1:00 PM | Making Sense of the Newer Drugs in IBD. A Pathophysiologic Approach to Rational Therapy, Dr. David Rubin, University of Chicago, Chicago, Illinois |
| 1:30 PM | Surveillance Colonoscopy - How Often and What Do You Need to Look For, Dr. Anita Afzali, University of Cincinnati, Cincinnati, Ohio |
| 1:50 PM | Discussions |
| 2:00 PM | Scar Adenoma, Residual Polyp: Risk for Cancer and When To Do Full Thickness Resection, Dr. Irving Waxman, Rush University, Chicago, Illinois |
| 2:20 PM | Optimizing Colonoscopy Outcomes - What Is the Right Metric To Use, Dr. Raj Keswani, Northwestern Medicine, Chicago, Illinois |
| 2:40 PM | Defect Closure - Clips/Suture/Surgery - What Are My Choices, Dr. Chris Chapman, Chicago, Illinois |
| 3:00 PM | Questions |
| 3:10 PM | Adjourn |
CONFERENCE PLANNING COMMITTEE
Lisa Cannon, RN, GI Associates, Milwaukee, Wisconsin
Sue Caskey, GI Associates, Milwaukee, Wisconsin
Kulwinder Dua, MD, Medical College of Wisconsin, Milwaukee, Wisconsin
Nalini Guda, MD, GI Associates, Milwaukee, Wisconsin
Katie Muenchow, GI Associates, Milwaukee, Wisconsin
Melissa Palmer, PA, GI Associates, Milwaukee, Wisconsin
Patrick Pfau, MD, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
CONFERENCE FACULTY
Anita Afzali, MD, University of Cincinnati, Cincinnati, Ohio
Rajeev Attam, MD, Kaiser Permanente Downey Medical Center, Downey, California
Amitabh Chak, MD, Case Western Reserve University, Cleveland, Ohio
Chris Chapman, MD, Chicago, Illinois
John DeWitt, MD, Indiana University, Indianapolis, Indiana
Martin Freeman, MD, University of Minnesota Medical School, Minneapolis, Minnesota
Prasad Iyer, MD, Mayo Clinic, Rochester, Minnesota
Raj Keswani, MD, MS, Northwestern Medicine, Chicago, Illinois
David Rubin, MD, University of Chicago, Chicago, Illinois
Carol Semrad, MD, University of Chicago, Chicago, Illinois
Reza Shaker, MD, Medical College of Wisconsin, Milwaukee, Wisconsin
Uzma Siddiqui, MD, University of Chicago, Chicago, Illinois
Nimish Vakil, MD, Clinical Adjunct Professor of Medicine, University of Wisconsin
Irving Waxman, MD, Rush University, Chicago, Illinois
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
NAME |
ROLE(S) |
FINANCIAL RELATIONSHIPS DISCLOSURE | DISCUSSION OF UNLABELED/ UNAPPROVED USES OF DRUGS/ DEVICES IN PRESENTATION? |
Anita Afzali, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Rajeev Attam, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Lisa Cannon, RN | Committee Member | No relevant relationships with ineligible companies to disclose | Yes |
Susan Caskey | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Amitabh Chak, MD | Speaker | Lucid Diagnostics – Patent for device and assays (Patent), Micro Tech, US Endoscopy (Both Contractor); Lucid Diagnostics (Stock) | No |
Chris Chapman, MD | Speaker | ERBE USA Inc., Allurion Technologies, Apollo Endosurgery US Inc., Boston Scientific Corporation, AbbVie, BFKW LLC, Nitinotes, Olympus America Inc., (All Contractor) | Yes |
John DeWitt, MD | Speaker | Vyaire Medical, Inc. (Grant) | No |
Kalwinder Dua, MD | Committee Member, Speaker |
Boston Scientific Corporation (Contractor) | No |
Martin Freeman, MD | Speaker | No relevant relationships with ineligible companies to disclose | Yes |
Nalini Guda, MD | Committee Member, Speaker | Hemostasis LLC, Boston Scientific Corporation (Both Contractor) | No |
Prasad Iyer, MD | Speaker | Castle Biosciences, CDx Diagnostics, Medtronic USA, Inc. (All Contractor); Exact, C2 Therapeutics, Inc. (Both Grant) | No |
Raj Keswani, MD, MS | Speaker | Virgo (Grant); Boston Scientific Corporation, Neptune Medical (Both Contractor) | No |
Cathy Means | Planner | No relevant relationships with ineligible companies to disclose | No |
Katie Muenchow | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Melissa Palmer, PA | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Patrick Pfau, MD | Committee Member, Speaker, Content Reviewer | No relevant relationships with ineligible companies to disclose | No |
David Rubin, MD | Speaker | Iterative Health, Bellatrix Pharmaceuticals, Alimentiv Inc., Gilead Sciences, Takeda Pharmaceutical Company, Seres Therapeutics, Trellus Health, Target RWE, Datos Health, Ironwood Pharmaceuticals, Inc., Prometheus, AbbVie, Kaleido Biosciences, Reistone Biopharma, Genentech, Bristol-Myers Squibb, EcoR1, Altrubio, Connect BioPharma, Janssen Biotech, Crohn's and Colitis Foundation, Pfizer, Arslan, Eli Lilly and Company, TechLab, Inc., ClostraBio, Athos Therapeutics, Evinature, Ltd., Celgene Corporation, Boehringer Ingelheim, Arena Pharmaceuticals (All Contractor); Altrubio, Datos Health (Both Stockoption); Takeda Pharmaceutical Company (Grant) | No |
Carol Semrad, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Reza Shaker, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Uzma Siddiqui, MD | Speaker | Cook Incorporated, Boston Scientific Corporation, Medtronic, Pinnacle Biologics, Inc., Olympus, CONMED Corporation (All Contractor) | Yes |
Nimish Vakil, MD | Speaker | Phathom, Merck, AstraZeneca, Isothrive (All Contractor) | No |
Irving Waxman, MD | Speaker | Boston Scientific Corporation, Medtronic, Wilson Cook Medical Incorporated (All Contractor) | No |
 | Accreditation StatementIn support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) and the Midwest Endoscopy Group Inc. Education Research Consortium. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements | |
American Medical Association (AMA) | The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
 | The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. |
American Nurses Credentialing Center (ANCC) | The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 5.75 ANCC contact hours. |
Continuing Education Units (CEUs) | The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for .575 continuing education units (CEUs) or 5.75 hours. |
Available Credit
- 5.75 AAPA Category 1 CME
- 5.75 AMA PRA Category 1 Credit™
- 5.75 ANCC Contact Hours
- 5.75 University of Wisconsin–Madison Continuing Education Hours
- 5.75 Approved for AMA PRA Category 1 Credit™
Price
CANCELLATION AND REFUND POLICY
Requests for cancellation must be submitted in writing to help@icep.wisc.edu. Cancellation requests received at least 96 hours prior to the conference will allow a full refund except for the nonrefundable processing fee of $25. No refunds will be made for cancellations received less than 96 hours prior to the activity start date.
Registration for this activity can only be completed through the ICEP Learning Portal. Attendee registrations made through any other sites cannot be honored. UW-Madison ICEP is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com. Please report any unauthorized websites or solicitations for registrations to info@icep.wisc.edu.
ACCESSIBILITY
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at help@icep.wisc.edu